Anderson - Plant innate immunity proteins

Our group works on protection of humans and crops from pathogens. We do this by studying natural defences of plants, and the biology of the pathogens themselves.

Binger - Immunometabolism and macrophage biology

Our research aims to understand the link between what immune cells ‘eat’ in our tissues and how this is connected to their normal biology and inflammatory diseases such as high blood pressure and diabetes.

Chen - T cell immunology

Our group specialises in CD8+ T cell biology and antigen processing and presentation, particularly in relation to the development of cross-protective immune responses to the influenza virus.

Fairlie - Apoptosis, autophagy, cancer, drug development and peptides

Our group use a combination of biochemistry, cell biology, structural biology and medicinal chemistry approaches to understand the precise molecular mechanisms that control apoptosis.

Foley - Single domain antibodies in human disease

Our group uses single domain antibodies that have been developed from sharks to identify novel therapeutics against a number of chronic diseases.

Gras – Viral and structural immunology

Our laboratory is focused on understanding how to combat viral infections.

Greening - Molecular proteomics, extracellular vesicles, intercellular signalling

Employ a multi-disciplinary approach to understand molecular function of extracellular vesicles and their re-engineering towards deliverable therapeutics.

Hawkins - Cell death regulation in cancer and viral infection

Our group examines apoptotic regulation in normal cells, cancerous cells and virally-infected cells. We use this knowledge to explore better and safer therapies for cancer and viral diseases.

Heras - Bacterial virulence factors: structure and function

Our group studies the molecular mechanisms underlying Gram-negative bacterial infections to develop antibacterial drugs that are not susceptible to existing resistance mechanisms.

Hill - Neurodegenerative diseases, extracellular vesicles and noncoding RNAs

Our group uses a combination of biochemistry, molecular and cell biology to investigate neurodegenerative diseases such as Alzheimer's, Prion and Parkinson's diseases.

Hoogenraad - Development of therapeutic antibodies against cachexia

Our group specialises in cancer cachexia, a complication of cancer that is responsible for around 25% of cancer deaths.

Hulett - Inflammation and tumour progression

Our group studies the molecular basis of tumour progression and inflammatory disease to develop novel anti-cancer and anti-inflammatory drugs.

Humbert - Cancer biology, cell polarity and tissue architecture

Our group is interested in how cell asymmetry and tissue organisation can regulate cancer initiation, progression and metastasis

Kvansakul - Structural biology of cell death and host-pathogen interactions

Our group examines how viruses hijack cellular defence systems to ensure their own proliferation and survival.

E Lee - Cell death and survival pathways

Our group examines the molecular mechanisms underlying cell fate decisions dictated by the processes of apoptosis and autophagy.

M Lee - Structural biology in gene regulation and DNA damage repair pathway

Our group characterises the macromolecular complexes in the nucleus to understand their roles in gene regulation and DNA damage repair pathway.

Mathivanan - Exosomes, secretome and systems biology

Our group explores the role of extracellular matrix components (soluble secreted proteins and extracellular vesicles) in cancer and intercellular communication.

Murphy - Skeletal muscle biochemistry

Our group studies the various aspects of skeletal muscle biochemistry in health and disease, using exercise and disease models in humans, as well as animal models.

Orian - Neurodegenerative diseases

Our group uses proof-of-concept to identify pathological and molecular mechanisms of disease. We also evaluate candidate MS drugs.

Poon - Apoptotic cell disassembly and clearance

Our group studies the machinery that control how dying cells can disassemble into smaller pieces, and the importance of cell disassembly in disease settings, to identify new drugs to control this process.

Puthalakath - Regulation of apoptosis by Bcl-2 family proteins

Our group researches the molecular basis of apoptosis regulation during heart failure, sepsis and in chemo resistance.

Reynolds - Self assembled nanomaterials

Our group uses self-assembling biomolecules as building blocks for nanomaterials with a range of biomedical and technological applications.

Richardson - Cell polarity, cell signalling and cancer

Our group uses the vinegar fly, Drosophila, to model cancer with the vision of understanding how regulators of cell shape (polarity) and the cell skeleton (actin cytoskeleton) impact on cell signalling and cancer development.

Simpson - Cancer secretome, extracellular communication, exosome and extracellular vesicle biology

Our group utilizes an integrated proteomic/genomic strategy to understand the role of the extracellular environment in cancer progression.

Soares da Costa - Antibiotic and herbicide discovery

Our group focuses on the development and characterisation of novel classes of antibiotics and herbicides to minimise the emergence of resistance.

Truscott - Mitochondrial protein homeostasis

Our group studies the function of mitochondrial proteins involved in the biogenesis and maintenance of mitochondria at the molecular level.

Warr - Neural signalling

Our group investigate how cells in the nervous system receive and respond to signals from their environment.

Wijeyewickrema - Proteases, inhibitors and receptors: relationship to disease states

Our group researches enzymes, called proteases, which operate at the interface between a host, such as a human being and microbes that cause disease.